Grantham, Mayo, Van Otterloo & Co (GMO)’s Paycom PAYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87M Buy
38,739
+15,788
+69% +$2.06M 0.01% 336
2026
Q1
$2.79M Buy
22,951
+14,644
+176% +$1.96M 0.01% 400
2025
Q4
$1.32M Buy
8,307
+3,250
+64% +$576K ﹤0.01% 465
2025
Q3
$1.05M Buy
5,057
+524
+12% +$118K ﹤0.01% 479
2025
Q2
$1.05M Buy
+4,533
New +$1.07M ﹤0.01% 476
2024
Q3
Sell
-10,769
Closed -$1.54M 588
2024
Q2
$1.54M Buy
+10,769
New +$1.85M 0.01% 375

Other funds holding PAYC

Grantham, Mayo, Van Otterloo & Co (GMO)'s PAYC Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Paycom (PAYC) stake by 69% in Q2 2026, buying an estimated $2.06M and bringing the position to 38,739 shares worth $4.87M. The position accounts for 0.01% of the portfolio, ranked #336.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PAYC in Q2 2024 and has held it in 6 quarters since. 599 funds tracked by Wall St. Rank hold PAYC as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 38,739 shares of Paycom worth $4.87M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 15,788 Paycom shares in Q2 2026, an estimated $2.06M.
  • Paycom made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #336 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Paycom in Q2 2024 and has held it in 6 quarters since.
  • 599 funds tracked by Wall St. Rank held Paycom as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.